Recognizing secondary infection in patients with atopic dermatitis: Head & neck atopic dermatitis; Распознавание вторичной инфекции у пациентов с атопическим дерматитом лица и шеи (head and neck)

Atopic dermatitis is a hereditary chronic skin disease characterized by severe itching, recurrent course and association with other diseases of atopic nature, as well as numerous complications, which include the addition of a secondary infection. Head and neck atopic dermatitis (HNAD) is a special phenotype of atopic dermatitis that occurs in adolescents and adults. A characteristic feature of HNAD is the lesion of skin areas rich in sebaceous glands (face, neck, upper third of the chest and back), which is associated with the active participation of Malassezia fungi in the pathogenesis of the dermatosis. The multifactorial pathogenesis of HNAD, often persistent course, the impossibility of complete elimination of the provoking factor, as well as the addition of a secondary bacterial infection against the background of itching, necessitate a comprehensive approach to the treatment of this condition and the use of combination drugs containing a glucocorticosteroid, an antimycotic and an antibiotic to relieve exacerbations. The article examines the etiology, mechanisms of development of HNAD, clinical features, as well as modern methods of therapy, the practical application of which is demonstrated in a clinical example: patient, 19 years old, complaining of itchy, flaky rashes in the face and neck area, existing for 3 weeks. Based on the clinical picture, a diagnosis was made: atopic dermatitis of the face and neck. Given the multifaceted cause of the condition, namely the participation of both a pronounced immune response characteristic of AD, active colonization by Malassezia fungi, as well as open “gates” for secondary bacterial infection in the form of erosions, the prescription of a topical glucocorticosteroid was pathogenetically justified. © 2025 Elsevier B.V., All rights reserved.

Авторы
Tamrazova Ol’Ga Borisovna 1, 2 , Tamrazova Anait V. 3 , Novik G.A. 4 , Zhdanova Marina V. 4 , Stadnikova Antonina Sergeevna 5 , Sukhotina Aleksandra G. 5
Издательство
Remedium Group Ltd
Номер выпуска
2
Язык
Russian
Страницы
42-48
Статус
Published
Том
19
Год
2025
Организации
  • 1 Department of Dermatovenerology with the course of Cosmetology, RUDN University, Moscow, Russian Federation
  • 2 Department of Dermatology, Bashlyaeva City Children’s Clinical Hospital, Moscow, Russian Federation
  • 3 The Department of Dermatovenerology and Cosmetology, Central State Medical Academy of the Department of Presidential Affairs of the Russian Federation, Moscow, Russian Federation
  • 4 Department of Children’s Diseases named after Professor I.M. Vorontsov, Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation
  • 5 Bashlyaeva City Children’s Clinical Hospital, Moscow, Russian Federation
Ключевые слова
atopic dermatitis; dupilumab; glucocorticosteroids; head and neck dermatitis; Malassezia spp
Цитировать
Поделиться

Другие записи

Avatkov V.A., Apanovich M.Yu., Borzova A.Yu., Bordachev T.V., Vinokurov V.I., Volokhov V.I., Vorobev S.V., Gumensky A.V., Иванченко В.С., Kashirina T.V., Матвеев О.В., Okunev I.Yu., Popleteeva G.A., Sapronova M.A., Свешникова Ю.В., Fenenko A.V., Feofanov K.A., Tsvetov P.Yu., Shkolyarskaya T.I., Shtol V.V. ...
Общество с ограниченной ответственностью Издательско-торговая корпорация "Дашков и К". 2018. 411 с.